Kristi Leonard
ScholarGPS® ID: 21950302771292
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | Cancer | Chemical Synthesis | Integrin
Metrics Summary
Publication Count
34
Predicted Citations
1,305
Predicted h-index
20
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Discovery of a Potent and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase with Oral Anti-Inflammatory Activity (journal article) ACS Medicinal Chemistry Letters, volume 12, issue 5, pages 782-790 (2021). |
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt (journal article) Bioorganic & Medicinal Chemistry Letters, volume 30, issue 12, pages 127205- (2020). |
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach (journal article) Bioorganic & Medicinal Chemistry Letters, volume 30, issue 12, pages 127174- (2020). |
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease (journal article) Journal of Medicinal Chemistry, volume 63, issue 6, pages 2915-2929 (2020). |
Identification and biological evaluation of thiazole-based inverse agonists of RORγt (journal article) Bioorganic & Medicinal Chemistry Letters, volume 28, issue 9, pages 1446-1455 (2018). |
Identification and biological evaluation of thiazole-based inverse agonists of ROR gamma t. (journal article) Bioorganic & Medicinal Chemistry Letters, volume 28, issue 9, pages 1446-1455 (2018). |
6-Substituted quinolines as RORγt inverse agonists (journal article) Bioorganic & Medicinal Chemistry Letters, volume 27, issue 23, pages 5277-5283 (2017). |
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt (journal article) Bioorganic & Medicinal Chemistry Letters, volume 27, issue 9, pages 2047-2057 (2017). |
Bioorganic & Medicinal Chemistry Letters, volume 23, issue 9, pages 2688-2691 (2013). |
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s (journal article) Bioorganic & Medicinal Chemistry Letters, volume 22, issue 16, pages 5303-5307 (2012). |
Patent Number: 20120302573 (2012) |
Design and Characterization of Optimized Adenosine A2A /A1 Receptor Antagonists for the Treatment of Parkinson's Disease (journal article) Journal of Medicinal Chemistry, volume 55, issue 3, pages 1402-1417 (2012). |
Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists (journal article) MedChemComm, volume 2, issue 10, pages 950- (2011). |
Bioorganic & Medicinal Chemistry Letters, volume 20, issue 9, pages 2868-2871 (2010). |
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s (journal article) Bioorganic & Medicinal Chemistry Letters, volume 18, issue 5, pages 1603-1606 (2008). |
Novel Potent and Selective αv β3 /αv β5 Integrin Dual Antagonists with Reduced Binding Affinity for Human Serum Albumin. (journal article) ChemInform, volume 37, issue 51 (2006). |
Novel 1,4‐Benzodiazepine‐2,5‐diones as Hdm2 Antagonists with Improved Cellular Activity. (journal article) ChemInform, volume 37, issue 39 (2006). |
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity (journal article) Bioorganic & Medicinal Chemistry Letters, volume 16, issue 13, pages 3463-3468 (2006). |
Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin (journal article) European Journal of Medicinal Chemistry, volume 41, issue 7, pages 847-861 (2006). |
Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists (journal article) Bioorganic & Medicinal Chemistry Letters, volume 16, issue 12, pages 3115-3120 (2006). |